Department of Clinical Pharmacy, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Trends Endocrinol Metab. 2024 Aug;35(8):745-757. doi: 10.1016/j.tem.2024.03.003. Epub 2024 Apr 12.
Omega-3 (n-3) polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid (DHA), have important roles in human nutrition and brain health by promoting neuronal functions, maintaining inflammatory homeostasis, and providing structural integrity. As Alzheimer's disease (AD) pathology progresses, DHA metabolism in the brain becomes dysregulated, the timing and extent of which may be influenced by the apolipoprotein E ε4 (APOE4) allele. Here, we discuss how maintaining adequate DHA intake early in life may slow the progression to AD dementia in cognitively normal individuals with APOE4, how recent advances in DHA brain imaging could offer insights leading to more personalized preventive strategies, and how alternative strategies targeting PUFA metabolism pathways may be more effective in mitigating disease progression in patients with existing AD dementia.
ω-3(n-3)多不饱和脂肪酸(PUFAs),如二十二碳六烯酸(DHA),通过促进神经元功能、维持炎症内稳态和提供结构完整性,在人类营养和大脑健康方面发挥着重要作用。随着阿尔茨海默病(AD)病理的进展,大脑中的 DHA 代谢变得失调,其时间和程度可能受到载脂蛋白 E ε4(APOE4)等位基因的影响。在这里,我们讨论了在认知正常的 APOE4 个体中,早期维持足够的 DHA 摄入如何减缓向 AD 痴呆的进展,DHA 脑成像的最新进展如何为更个性化的预防策略提供见解,以及针对 PUFA 代谢途径的替代策略如何在减轻已有 AD 痴呆患者的疾病进展方面更有效。